Use of Paliperidone Palmitate Throughout a Schizoaffective Disorder Patient’s Gestation Period

Abstract

Introduction: Paliperidone palmitate treatment of schizophrenia or schizoaffective disorder is effective and well tolerated, but there is almost no data on its safety during pregnancy.

Case report: An analysis is made of the safety and tolerability of paliperidone palmitate treatment throughout the gestation period in a 34-year-old patient diagnosed with schizoaffective disorder.

Discussion: Paliperidone palmitate treatment throughout the gestation period was safe and well tolerated by both mother and foetus, there being no malformations or other perinatal complications in the newborn to date.

Key words

schizoaffective disorder - pregnancy - paliperidone palmitate - safety - antipsychotic treatment

• References

• 1 Kim S, Solari H, Weiden PJ et al. Paliperidone palmitate injection for the acute and maintenance treatment of schizophrenia in adults. Patient Prefer Adherence 2012; 6: 533-545
• 2 Oyebode F, Rastogi A, Berrisford G et al. Psychotropics in pregnancy: safety and other considerations. Pharmacology and therapeutics 2012; 135: 71-77
• 3 Vigod SN, Gomes T, Wilton AS et al. Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study. BMJ 2015; 350: h2298
• 4 Wichman CL. Atypical antipsychotic use in pregnancy: a retrospective review. Arch Womens Ment Health 2009; 12: 53-57
• 5 Özdemir AK, Pak SC, Canan F et al. Paliperidone palmitate use in pregnancy in a woman with schizophrenia. Arch Womens Ment Health 2015; 739-740
• 6 Fernández I, Álvarez E. Estudio Llevant. El desarrollo psicomotor de 1.702 niños de 0 a 24 meses. Tesis Doctoral, Universidad de Barcelona 1989
• 7 Iceta A, Yoldi ME. Psychomotor development of the child and its evaluation in primary care. An Sist Sanit Navar 2002; 25 (Suppl. 02) 35-43
• 8 Xeplion® Data Sheet Janssen-Cilag International, 2011, updated 2015
• 9 Paisán L, Sota I, Muga O et al. El recién nacido de bajo peso. Protocolos Diagnóstico Terapeúticos de la Asociación Española de Pediatría: Neonatología 2008; 78-84
• 10 Cohen LS, Viguera AC, McInerney KA et al. Reproductive safety of second-generation antipsychotics: current data rrom the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Am J Psychiatry 2016; 173: 263-270
• 11 Kulkarni J, Storch A, Baraniuk A et al. Antipsychotic use in pregnancy. Expert Opin Pharmacother 2015; 16: 1335-1345